'Oral treatment for COVID to be available by late 2021'
The new drug is a protease inhibitor that prevents the virus from replicating in cells, Albert Bourla says.
The new drug is a protease inhibitor that prevents the virus from replicating in cells, Albert Bourla says.
The Health Ministry expects to receive approval from the Food and Drug Administration by early May, and begin the children's inoculation campaign at the end of next month.
Given the prevailing expectation that PM Netanyahu is unlikely to receive an extension should he fail to form a government before his mandate expires, the party leaders sit down to discuss their various positions.
Sa'ar, a former Likud challenger to Netanyahu who ran against him in the March 23 election and vowed not to sit in his government, may accept deal in which he would not have to sit under incumbent.
Shas leader Aryeh Deri says he "has no interest in becoming prime minister." Over on the Center-Left bloc, hiccups in negotiations have insiders warn that Yesh Atid leader Yair Lapid's "amateurism will see Netanyahu remain in power."
The local Jewish population has shown outpouring support to struggling institutions and social projects, both inside and outside the community.
Scary pictures are emerging from all over the country. There are rows of dead bodies awaiting their turn at the crematoriums.
'Le Parisien' reports that "Tel Aviv is no longer hiding its face behind a mask."
A Midgam survey for "Meet the Press" finds that were elections held at this time, Likud would win 30 seats, but 43% of the public would hold PM Netanyahu responsible for their fifth trip to the polls in two years.
Clalit Research Institute study finds that the vaccine is 80% effective against symptomatic infection for people with heart or chronic kidney diseases, 86% for people with type 2 diabetes, 75% for cerebrovascular disease, and 84% for people suffering from immunodeficiency.
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]